Dr. Uzzo on the Guidelines for the Management of Kidney Cancer

Robert G. Uzzo, MD
Published: Thursday, Sep 28, 2017



Robert G. Uzzo, MD, chair, Surgical Oncology, G. Willing "Wing" Pepper Chair in Cancer Research, senior vice president, Physician Services, president, Fox Chase Cancer Center Medical Group, Inc., professor of surgery, Temple University Health System, Fox Chase Cancer Center, discusses the guidelines for the treatment and management of patients with kidney cancer.

There is an increasing emphasis on biopsy to determine and risk-stratify patients prior to any plans for excision, ablation, or observation. The use of percutaneous biopsy as a risk-stratifying tool is an important aspect of all the guidelines.

Many physicians believe that biopsy is associated with a risk of tumor spillage, which fortunately is not the case, states Uzzo. Biopsy does not seem to be associated with a higher-risk of tumor dissemination.
 
SELECTED
LANGUAGE


Robert G. Uzzo, MD, chair, Surgical Oncology, G. Willing "Wing" Pepper Chair in Cancer Research, senior vice president, Physician Services, president, Fox Chase Cancer Center Medical Group, Inc., professor of surgery, Temple University Health System, Fox Chase Cancer Center, discusses the guidelines for the treatment and management of patients with kidney cancer.

There is an increasing emphasis on biopsy to determine and risk-stratify patients prior to any plans for excision, ablation, or observation. The use of percutaneous biopsy as a risk-stratifying tool is an important aspect of all the guidelines.

Many physicians believe that biopsy is associated with a risk of tumor spillage, which fortunately is not the case, states Uzzo. Biopsy does not seem to be associated with a higher-risk of tumor dissemination.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Rapid Reviews in Oncology®: Practice-Changing Data in Acute Myeloid Leukemia: A Rapid Update From Atlanta OnlineDec 21, 20182.0
Community Practice Connections™: 2nd Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesDec 30, 20182.0
Publication Bottom Border
Border Publication
x